Hamid Ehsan
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
Papers in
- Hematology 24
- Multiple Myeloma Research and Treatments 18
-
- Protein Degradation and Inhibitors 7
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Co-authors
- Ahsan Wahab (25 shared papers)Abdul Rafae (11 shared papers)Muhammad Nadeem Yousaf (6 shared papers)Muhammad Khawar Sana (12 shared papers)Kamran Mushtaq (2 shared papers)Faiz Anwer (16 shared papers)Raheel Iftikhar (4 shared papers)Hamza Hashmi (5 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (3 papers)Transplantation and Cellular Therapy (2 papers)Bone Marrow Transplantation (1 paper)Medicine (1 paper)
- Partner nations
- United StatesPakistanNepal
In The Last Decade
Hamid Ehsan
42 papers receiving 353 citations
Peers
Comparison fields: 5 of 68
- Hematology 78
- Oncology 96
- Pulmonary and Respiratory Medicine 90
- Genetics 29
- Hepatology 19
Countries citing papers authored by Hamid Ehsan
This map shows the geographic impact of Hamid Ehsan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Ehsan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Ehsan more than expected).
Fields of papers citing papers by Hamid Ehsan
This network shows the impact of papers produced by Hamid Ehsan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Ehsan. The network helps show where Hamid Ehsan may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamid Ehsan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 80 | |
| 2 | 2021 | 60 | |
| 3 | 2021 | 34 | |
| 4 | 2020 | 15 | |
| 5 | 2020 | 13 | |
| 6 | 2022 | 10 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2020 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2020 | 5 |
About Hamid Ehsan
Hamid Ehsan is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 361 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Hepatitis B Virus Studies (3 papers), Blood donation and transfusion practices (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Hematology (78 citations), Oncology (96 citations), Pulmonary and Respiratory Medicine (90 citations), Genetics (29 citations) and Hepatology (19 citations). Hamid Ehsan has collaborated with scholars based in United States, Pakistan and Nepal. Frequent co-authors include Ahsan Wahab, Abdul Rafae, Muhammad Nadeem Yousaf, Muhammad Khawar Sana, Kamran Mushtaq, Faiz Anwer, Raheel Iftikhar, Hamza Hashmi, Craig J. Thomas and Mark J. Caulfield. Their work appears in journals such as Blood, Journal of Clinical Oncology, Transplantation and Cellular Therapy, Bone Marrow Transplantation and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.